Ainsworth S B, Clerihew L, McGuire W
NHS Fife (Acute Hospitals), Directorate of Women and Children's Health, Forth Park Hospital, Bennochy Road, Kirkcaldy, Fife, UK, KY2 5RA.
Cochrane Database Syst Rev. 2007 Jul 18(3):CD004219. doi: 10.1002/14651858.CD004219.pub3.
Parenteral nutrition for neonates may be delivered via a short peripheral cannula or a central venous catheter. The latter may either be inserted via the umbilicus or percutaneously. Because of the complications associated with umbilical venous catheter use, many neonatal units prefer to use percutaneously inserted catheters following the initial stabilisation period. The method of parenteral nutrition delivery may affect nutrient input and consequently growth and development. Although potentially more difficult to place, percutaneous central venous catheters may be more stable than peripheral cannulae, and need less frequent replacement. These delivery methods may also be associated with different risks of adverse events, including acquired systemic infection and extravasation injury.
To determine the effect of infusion via a percutaneous central venous catheter versus a peripheral cannula on nutrient input, growth and development, and complications including systemic infection, or extravasation injuries in newborn infants who require parenteral nutrition.
The standard search strategy of the Cochrane Neonatal Review Group was used. This included searches of the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 1, 2007), MEDLINE (1966 - February 2007), EMBASE (1980 - February 2007), conference proceedings, and previous reviews.
Randomised controlled trials that compared the effect of delivering parenteral nutrition via a percutaneous central venous catheter versus a peripheral cannulae in neonates.
Data were extracted the data using the standard methods of the Cochrane Neonatal Review Group, with separate evaluation of trial quality and data extraction by each author, and synthesis of data using relative risk, risk difference and mean difference.
Four trials eligible for inclusion were found. These trials recruited a total of 368 infants and reported a number of different outcomes. One study showed that the use of a percutaneous central venous catheter was associated with a decreased risk of cumulative nutritional deficit during the trial period: Mean difference in the percentage of the prescribed nutritional intake actually received: -7.1% (95% confidence interval -11.02, -3.2). In another trial, infants in the percutaneous central venous catheter group needed significantly fewer catheters/cannulae per infant during the trial period: Mean difference in the number of catheters/cannulae per infant: -3.2 (95% confidence interval -5.13, -1.27). Meta-analysis of data from all four trials did not find any evidence of an effect on the incidence of systemic infection: Typical relative risk: 0.94 (95% confidence interval 0.70, 1.25); typical risk difference: -0.02 (95% confidence interval -0.12, 0.08).
AUTHORS' CONCLUSIONS: Data from one small study suggest that the use of a percutaneous central venous catheter to deliver parenteral nutrition in newborn infants improves nutrient input. The significance of this in relation to long-term growth and developmental outcomes is unclear. Another study suggested that the use of a percutaneous central venous catheter rather than a peripheral cannula decreases the number of catheters/cannulae needed to deliver the nutrition. No evidence was found to suggest that percutaneous central venous catheter use increased the risk of adverse events, particularly systemic infection.
新生儿肠外营养可通过外周短导管或中心静脉导管进行输注。后者可经脐部插入或经皮插入。由于脐静脉导管使用存在并发症,许多新生儿病房倾向于在初始稳定期后使用经皮插入的导管。肠外营养的输注方式可能影响营养物质的输入,进而影响生长发育。尽管经皮中心静脉导管可能更难放置,但可能比外周导管更稳定,且更换频率更低。这些输注方式也可能与不同的不良事件风险相关,包括获得性全身感染和外渗损伤。
确定在需要肠外营养的新生儿中,经皮中心静脉导管输注与外周导管输注对营养物质输入、生长发育以及包括全身感染或外渗损伤在内的并发症的影响。
采用Cochrane新生儿综述小组的标准检索策略。检索内容包括Cochrane对照试验中心注册库(CENTRAL,Cochrane图书馆,2007年第1期)、MEDLINE(1966年至2007年2月)、EMBASE(1980年至2007年2月)、会议论文集以及以往的综述。
比较经皮中心静脉导管与外周导管在新生儿中输注肠外营养效果的随机对照试验。
使用Cochrane新生儿综述小组的标准方法提取数据,每位作者分别评估试验质量和提取数据,并使用相对风险、风险差值和均值差值进行数据综合分析。
共纳入4项符合条件的试验。这些试验共招募了368名婴儿,并报告了许多不同的结果。一项研究表明,在试验期间使用经皮中心静脉导管可降低累积营养不足的风险:实际摄入的规定营养摄入量百分比的均值差值为-7.1%(95%置信区间-11.02,-3.2)。在另一项试验中,经皮中心静脉导管组的婴儿在试验期间每名婴儿所需的导管/套管显著减少:每名婴儿的导管/套管数量的均值差值为-3.2(95%置信区间-5.13,-1.27)。对所有4项试验的数据进行荟萃分析未发现对全身感染发生率有影响的证据:典型相对风险为0.94(95%置信区间0.70,1.25);典型风险差值为-0.02(95%置信区间-0.12,0.08)。
一项小型研究的数据表明,在新生儿中使用经皮中心静脉导管进行肠外营养可改善营养物质输入。这与长期生长发育结局的关系尚不清楚。另一项研究表明,使用经皮中心静脉导管而非外周导管可减少营养输注所需的导管/套管数量。未发现证据表明使用经皮中心静脉导管会增加不良事件风险,尤其是全身感染风险。